Assenagon Asset Management S.A. bought a new position in Enovis Co. (NYSE:ENOV – Free Report) during the 4th quarter, ...

Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

Enovis (NYSE: ENOV) announced today that it appointed Davide Visentin as the new president of its International Surgical ...

Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin Reinmann as President of Enovis International ...

Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr ...

Enovis, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin Reinmann ...

In a report released yesterday, Vik Chopra from Wells Fargo reiterated a Buy rating on Enovis (ENOV – Research Report), with a price target of ...

WILMINGTON, DE - Enovis (NYSE: ENOV), a prominent medical technology company with a market capitalization of $2.54 billion, has announced the appointment of Davide Visentin as the new President of ...

On Monday, Enovis Corp (ENOV) stock saw a modest uptick, ending the day at $45.35 which represents a slight increase of $0.58 or 1.30% from the prior close of $44.77. The stock opened at $44.43 and ...